Sano blog | rare disease (10)

rare disease genetic testing podcast recap

Innovation on Rare Disease Day: Recode CMO John Matthews on changing the future of genetic medicine [podcast]

In observance of Rare Disease Day, our latest episode of the Genetics Podcast presents a fascinating conversation with John Matthews, who was recently promoted ...

precision medicine rare disease genetic testing

New frontiers in rare disease research

In the ever-evolving field of rare disease research, it's crucial to remain informed about the latest progress. At Sano, our commitment is to stay ahead of thes...

biomarkers rare disease

Natural history studies in the era of AI

Natural history studies play a pivotal role in understanding how diseases develop and progress over time. These observational studies track disease trajectories...

precision medicine rare disease podcast recap

A precision medicine year in review

As the new year unfolds, it's a time for reflection on some of the most inspirational stories in human genetics last year, and anticipation of what's to come in...

precision medicine rare disease genetic testing

Webinar recap: Genetics essentials for clinical research professionals

In this webinar, Sano co-founder and CEO Patrick Short discusses the essentials of genetics and genomics, including genetic variation, genetic testing, and more...

patient recruitment rare disease

Navigating rare disease patient recruitment

Rare diseases may impact a small portion of the population, yet their significance is profound. And while rare disease patient recruitment might seem similar to...

industry report rare disease genetic testing

Alpha-1 Antitrypsin Deficiency report: Impact and diagnosis

Our latest insights report focuses on Alpha-1 Antitrypsin Deficiency (AATD), a rare genetic disorder with significant implications for both lung and liver healt...

biomarkers precision medicine rare disease

Unravelling the complexities of genomics-driven drug discovery [whitepaper]

Genomics-based drug discovery offers great potential for the development of targeted therapies that can offer new and better treatment options for patients. By ...

data privacy rare disease genetic testing

The promising power and ethical considerations of newborn sequencing (inspired by the World Orphan Drug Congress USA)

Recently, our team was honoured to attend the World Orphan Drug Congress USA in Boston. The event brought together key stakeholders, experts, and industry leade...